Angewandte
Chemie
DOI: 10.1002/anie.201204083
RNA Structures
19
Investigation of RNA–Ligand Interactions by F NMR Spectroscopy
Using Fluorinated Probes**
Thomas Lombꢀs, Roba Moumnꢁ, Valꢁry Larue, Elise Prost, Marjorie Catala, Thomas Lecourt,
Frꢁdꢁric Dardel, Laurent Micouin,* and Carine Tisnꢁ*
Ribonucleic acid (RNA) is now recognized as playing a key
role in many biological functions, and is emerging as an
important new drug target.[1] However, its therapeutic poten-
tial is still underexploited.[2] Indeed, the limited understand-
ing of the interactions between small molecules and RNA still
hampers rational drug development of RNA-targeting mol-
ecules. Among the different methods available to investigate
binding between small molecules and RNA,[3] NMR spec-
troscopy is particularly attractive as it can deliver information
on molecular interactions at the atomic level, including
conformational rearrangements that can occur before or
upon binding.[4] The dynamic nature of this interaction is
particularly important in RNA-regulated pathways.[5]
site.[8] The use of ligand-based binding-competition NMR
screening using fluorinated ligands has been described by
Dalvit for the investigation of protein–ligand interactions
(FAXS technique),[9] but has not been applied to the study
small molecules interacting with RNA. We report herein that
competitive binding of fluorinated probes can be used to
detect and quantify the interaction between unlabeled RNA
and non-fluorinated ligands and to monitor dynamic RNA
folding events (Figure 1).
Many NMR spectroscopy techniques have been devel-
oped to visualize dynamic RNA–ligand interactions, most of
them based on the observation of either the target or ligand
1H nuclei.[6] However, some difficulties can occur when
studying larger strands of RNA, as the number of detectable
signals will increase. Introducing a specific label is one way to
overcome this problem. An elegant method based on
19F NMR spectroscopy was proposed some years ago by
Micura and co-workers. Introduction of a fluorine atom at
a specific position of RNA allows local monitoring of binding
events at this site.[7] One technical difficulty with this
approach is the need to chemically modify the RNA, which
can be difficult for large RNAs or for RNAs with modified
nucleotides. Furthermore, this modification can affect RNA–
ligand interactions.
Figure 1. Principle of the displacement experiments. A) Competition
for binding to a structured RNA between a fluorinated probe (F, star)
and an RNA ligand (L, hexagon). B) Competition for binding to a bi-
stable RNA. In both cases, the fluorinated reporter is monitored by
19F NMR.
The binding of aminoglycosides with 16S23 RNA,
a 23 nucleotide hairpin that mimics the decoding A-site of
16S ribosomal RNA, was first investigated as a case study.
Although absolute KD values are difficult to compare since
experimental conditions significantly vary from one study to
another, the KD values of the most studied ligands of 16S A-
site RNA can be ordered as follows: neomycin < paromomy-
cin < neamine < paromamine, neomycin being the strongest
binder and paromamine the weakest.[10] Fluorinated com-
pound 1 being an analogue of desoxystreptamine (DOS), the
core moiety of most aminoglycosides, we first checked that it
bound to the 16S23 RNA.[11] Its binding was monitored using
both 19F and 1H NMR spectroscopy (Figure 2). A KD of 2 mm
was determined by NMR titration. As reported for DOS,[12]
compound 1 interacts with two equivalent binding sites of
16S23 RNA in a fast-exchange regime.[13]
We then conducted ligand-based binding competition
using compound 1 as a fluorinated spy probe and known
binders of 16S23 RNA (neamine 2, paromamine 3, neomycin
4) as competitors. Progressive displacement of the fluorinated
reporter could be observed by increasing the concentration of
the competitor (Figure 3), the KD value of paromamine,
neamine, and neomycin for 16S23 could be estimated in the
We have recently shown that 19F NMR spectroscopy can
be used to monitor the binding of racemic fluorinated
molecules to various RNAs and that chiral recognition can
be used to monitor the local conformation of the binding
[*] T. Lombꢀs, Dr. R. Moumnꢁ, E. Prost, Dr. T. Lecourt, Dr. L. Micouin
UMR 8638 University Paris Descartes, CNRS, Facultꢁ de Pharmacie
4 av. de l’Observatoire, 75006 Paris (France)
E-mail: laurent.micouin@parisdescartes.fr
Dr. V. Larue, M. Catala, Prof. F. Dardel, Dr. C. Tisnꢁ
UMR 8015 University Paris Descartes, CNRS, Facultꢁ de Pharmacie
4 av. de l’Observatoire, 75006 Paris (France)
E-mail: carine.tisne@parisdescartes.fr
que10
[**] Financial support from CNRS Bettencourt Schueller Foundation
(PhD grant to T.L.), ANRS (grant to R.M.) and ANR (research
project PCV TriggeRNA) is acknowledged.
Supporting information for this article (experimental details) is
Angew. Chem. Int. Ed. 2012, 51, 1 – 6
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1
These are not the final page numbers!